Alzheimer’s Accountability and Investment Act
Latest Action
Became Public Law No: 118-93.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Alzheimer's Accountability and Investment Act, introduced in the 118th Congress as Senate Bill 134, focuses on addressing Alzheimer's disease through increased accountability and investment. Although the official summary and full text are not available, the bill's title and policy area indicate an emphasis on health-related initiatives targeting Alzheimer's disease. The bill was enacted into law as Public Law No: 118-93 on October 1, 2024, but its status is marked as Failed / Expired, suggesting it did not advance in its original form or was superseded by other legislation.
This bill aimed to enhance efforts against Alzheimer's disease through accountability and investment measures but did not progress as an active statute despite becoming Public Law No: 118-93.
- The bill is focused on Alzheimer's disease within the health policy area.
- It was introduced in the Senate during the 118th Congress as S.134.
- The bill became Public Law No: 118-93 on October 1, 2024, but is currently listed as Failed / Expired.
["Individuals affected by Alzheimer's disease", "Healthcare providers and researchers specializing in Alzheimer's", 'Federal health agencies involved in disease research and management']
['Lack of available full text limits assessment of specific implementation mechanisms and funding provisions.', 'The status of Failed / Expired may indicate challenges in legislative support or execution.', 'Oversight and accountability measures are not detailed due to missing text.']
The bill was introduced in the Senate during the 118th Congress and relates to ongoing federal efforts to address Alzheimer's disease. Its enactment as Public Law No: 118-93 indicates some level of legislative approval, but the designation as Failed / Expired suggests it did not become an active or sustained program. No further legislative history or summary is provided to clarify its trajectory.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
["Potential increased federal funding and research focus on Alzheimer's disease if provisions included investment measures.", "Possible enhancement of accountability frameworks within federal health agencies related to Alzheimer's programs.", "Improved public awareness and prioritization of Alzheimer's disease as a health policy issue."]
The absence of the bill's full text and official summary limits transparency and public understanding of the specific measures enacted. The conflicting status information between becoming law and being marked as failed or expired warrants clarification to ensure accurate tracking of legislative outcomes and implementation responsibilities.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.